Navigation Links
InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems

LOS ANGELES, March 3, 2011 /PRNewswire/ -- InstaCare Corp. (OTC Bulletin Board: ISCR), a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary patent pending cell phone centric e-health products and technologies, today announced that it has migrated its recently patent pending MD@Hand and MD@Work technologies for application to the highly touted Smart Pad computers.

The Company announced that it has received inquiries from two traditional healthcare companies and a major smart phone company with expressions of interest, or formal plans. Management is evaluating options with each of the potential partners and has initially agreed to migrate its MD@Hand and MD@Work technologies to the Apple iPad, Motorola Xoom, Blackberry Playbook and Samsung Galaxy tablet (pad) computer systems. The company estimates that the technology migration will be complete within 60 days.

Keith Berman, CFO and Secretary of InstaCare commented, "We have received inquiry from two traditional healthcare service companies and a large smart phone provider. Each of these organizations has voiced unique needs and has determined that to catch up to the rapidly evolving EMR/EHR standards as well as offering the highly exciting e-detailing service to pharmaceutical companies, they have to move quickly.  We continue to believe that our best available alternative would be to form partnerships to market our technology to new and alternative markets."

Mr. Berman continued, "We remain totally committed to monetizing our game-changing and recently patented technologies.  The market reaction, including inquiries and proposals from traditional healthcare service companies and a smart phone provider has reinforced our confidence that we have not only the ideal product for the new healthcare marketplace, but perhaps our cell phone-centric solution is the only completed and ready-to-deploy product that will work in an environment where mandates are the order of the day."

For more information about InstaCare Corp., Pharma Tech Solutions, Inc. MD@Hand, MD@Work and/or its revolutionary Genstrip please visit the InstaCare web site or or call the company at (805) 446-2973.

Forward-Looking StatementsForward-looking statements are statements made herein which do not address historical facts and, therefore could be interpreted to be forward-looking statements.  We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions. All forward-looking statements are intended to be covered by the safe harbor created by Section 21E of the Securities Exchange Act of 1934.  Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The forward-looking statements included in this press release represent our views as of March 3, 2011.  We anticipate that subsequent events and developments will cause our views to change.Contact: Keith Berman, Secretary and CFOinfo@instacare.net2660 Townsgate Road Suite 300 Westlake Village, CA 91361Ph : 805-446-1973 Fax: 805-446-1983

SOURCE InstaCare Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters
2. Instacare Corp. Board of Directors Sets Growth Plans for 2010
3. Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products
4. InstaCare Corp. to Announce Guidance on Its Genstrip Product Line on January 10, 2011
5. InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA
6. InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies
7. InstaCare Announces Receipt of Technology and Patent Value Analysis Penned by Joseph Wolf, Ph.D and William Walling, CFA
8. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
9. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
10. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
11. FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia
Post Your Comments:
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):